Myasthenia Gravis and Thymoma
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li · 2026
Read Myasthenia Gravis and Thymoma by Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13549168.txt.
Description
Benjamin Claytor and colleagues review the intertwined conditions of thymoma and myasthenia gravis, in a 2026 clinical article. The thymoma is a tumor of the gland behind the breastbone, the commonest in that chest compartment. Roughly a fifth to a third of patients with one develop myasthenia gravis, an autoimmune muscle weakness. Nearly all such patients carry antibodies against the acetylcholine receptor, and their weakness tends to be widespread and stubborn.
Contrast CT scanning is the workhorse for finding and sizing the tumor. MRI and PET play supporting roles. Surgery is advised for every thymoma, since all are considered malignant. Keyhole approaches now match open surgery for early stages, with fewer complications. The review covers preparing stable patients, the small risk of new weakness after surgery, and added drug and radiation treatment for advanced tumors. Returning weakness, it notes, can signal recurrence.
Catalog record
| CREATOR | Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64345 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |